NMR in target driven drug discovery: why not?

Area of Science:

• Biophysics
• Medicinal Chemistry
• Chemical Biology

Background:

• Drug discovery relies on consistent, reliable data on ligand-protein interactions.
• Various biophysical binding assays (e.g., TR-FRET, SPR, thermophoresis) exist, each with limitations.
• Nuclear Magnetic Resonance (NMR) spectroscopy offers a powerful, information-rich, and broadly applicable alternative.

Purpose of the Study:

• To demonstrate the utility of NMR in supporting early-stage drug discovery.
• To provide examples of NMR applications in a commercial drug discovery setting.
• To highlight NMR's role in enabling and supporting pre-clinical small molecule drug discovery.

Main Methods:

• Utilized Nuclear Magnetic Resonance (NMR) spectroscopy.
• Presented examples of NMR applications in small molecule drug discovery.
• Focused on methods suitable for commercial settings, emphasizing speed, cost-effectiveness, and ease of implementation.

Main Results:

• Demonstrated the broad applicability and information richness of NMR.
• Showcased NMR's effectiveness in providing crucial data for ligand-protein interactions.
• Illustrated NMR's value in supporting early pre-clinical drug discovery phases.

Conclusions:

• NMR is a highly valuable tool for small molecule drug discovery.
• NMR enables and supports early pre-clinical drug discovery with speed and cost-effectiveness.
• NMR provides reliable and comprehensive data crucial for identifying and optimizing drug candidates.